Annual report [Section 13 and 15(d), not S-K Item 405]

STOCK WARRANTS

v3.25.1
STOCK WARRANTS
12 Months Ended
Dec. 31, 2024
Stock Warrants  
STOCK WARRANTS

NOTE 10 – STOCK WARRANTS

 

On March 3, 2023, the Company entered into an agreement with Ross Sklar for 114,286 warrants to purchase shares of Class A common stock to be issued as a funding fee for the $800,000 secured promissory note (see Note 9). The warrants were valued using the Black-Scholes option pricing model under the following assumptions as found in the table below.

 

On June 1, 2023, the Company entered into an agreement with a consultant for services to be performed. As consideration therefore, the Company granted the consultant stock warrants to purchase 150,000 shares of common stock. The warrants vest over a three-year term. The warrants were valued using the Black-Scholes option pricing model under the following assumptions as found in the table below.

 

Date   Number of Stock Warrants     Stock Price     Strike Price     Expected Volatility     Interest Rate     Warrants and Rights Outstanding, Measurement Input     Expected Term     Fair Value  
                            Risk-                    
    Number of                       free                    
    Stock     Stock     Strike     Expected     Interest     Dividend     Expected     Fair  
Date   Warrants     Price     Price     Volatility     Rate     Rate     Term     Value  
03/03/2023     114,286     $ 0.17     $ 0.01       137.62 %     4.26 %     0.00 %     5.0 years     $ 18,710  
06/01/2023     150,000     $ 0.12     $ 0.19       150.24 %     3.70 %     0.00 %     3.0 years     $ 14,013  

 

 

A summary of the status of the Company’s outstanding stock warrants and changes during the periods is presented below:

 

    Shares available
to purchase
with warrants
    Weighted Average
Exercise Price
    Weighted-Average
Remaining Contractual
Term (in years)
    Aggregate
Intrinsic Value
 
Outstanding, December 31, 2022     41,085,714     $ 0.24       4.64     $ 45,714  
Issued     264,286       0.11       4.88       15,886  
Expired     2,000,000       1.05       -       -  
Outstanding, December 31, 2023     39,350,000     $ 0.20       3.87     $ 61,600  
                                 
Outstanding, December 31, 2023     39,350,000     $ 0.20       3.87     $ 61,600  
Expired     (250,000 )     1.00       -       -  
Outstanding, December 31, 2024     39,100,000     $ 0.19       2.88     $ 21,000  
                                 
Exercisable, December 31, 2024     29,438,863     $ 0.19       2.88     $ 21,000  

 

The fair value of stock warrants granted and vested during the year ended December 31, 2024 was zero and $1,564,350, respectively.

 

The fair value of stock warrants granted and vested during the year ended December 31, 2023 was $32,723 and $1,607,901 respectively.

 

The following table summarizes information about stock warrants to purchase shares of the Company’s common stock outstanding and exercisable as of December 31, 2024:

 

            Weighted-     Weighted-        
            Average     Average        
Range of     Outstanding     Remaining Life     Exercise     Number  
exercise prices     Warrants     In Years     Price     Exercisable  
$ 0.90       300,000       0.75     $ 0.90       300,000  
  0.19       38,300,000       2.90       0.19       28,638,863  
  0.20       100,000       2.84       0.20       100,000  
  0.01       400,000       3.05       0.01       400,000  
          39,100,000       2.88     $ 0.19       29,438,863  

 

The compensation expense attributed to the issuance of the stock warrants is recognized as they vest.

 

Total compensation expense related to the stock warrants was $1,564,350 and $1,589,191 for the years ended December 31, 2024 and 2023, respectively and was included in compensation expense on the statement of operations. As of December 31, 2024, there was $1,190,594 in future compensation cost related to non-vested stock warrants.

 

The aggregate intrinsic value as of December 31, 2024 is $21,000 for total outstanding and exercisable warrants, which was based on our estimated fair value of the common stock of $0.06, had all warrant holders exercised their warrants as of that date, net of the aggregate exercise price.